Search for: "Onglyza Product Cases"
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
5 Oct 2016, 10:37 am
The law limits the amount of time you have to file a claim, so contact us now to discuss your case. [read post]
12 Feb 2018, 12:05 pm
However, at the present time we are investigating heart failure cases for patients who used Onglyza or Kombiglyze as well as patients who used Nesina, Kazano, Oseni, or Qtern. [read post]
13 Apr 2015, 2:51 pm
Since 2008, the FDA has asked manufacturers of drugs for type 2 diabetes to provide evidence the products don’t increase the risk of heart attack or other cardiovascular events. [read post]
21 Feb 2018, 1:40 pm
IN RE: Onglyza (Saxagliptin) and Kombiglyze XR (Saxagliptin and Metformin) Products Liability Litigation MDL-2809 Number of lawsuits pending: 84 Diabetes drugs in this MDL case: Onglyza (saxagliptin) Kombiglyze XR (saxagliptin and metformin) Primary side effect for these cases: Heart Failure Get more information about these drug injury cases and/or free case evaluation. [read post]
11 May 2023, 11:56 am
The Onglyza Product Cases, A165387 decided on April 19, 2023 by the First District Court of Appeal is a case to be aware of. [read post]
7 Jan 2014, 5:19 pm
” The product liability cases are centralized before U.S. [read post]
17 Jul 2018, 12:31 pm
Onglyza Also for the treatment of type 2 diabetes, Onglyza has its own set of serious health risks. [read post]
17 Jul 2018, 12:31 pm
Onglyza Also for the treatment of type 2 diabetes, Onglyza has its own set of serious health risks. [read post]
17 Jul 2018, 12:31 pm
Onglyza Also for the treatment of type 2 diabetes, Onglyza has its own set of serious health risks. [read post]
20 Mar 2016, 6:34 pm
Mylan filed ANDAs in connection with Ampyra® (dalfampridine), Onglyza® (saxagliptin), and Kombiglyze® (saxagliptin/metformin). [read post]
20 Mar 2016, 6:34 pm
Mylan filed ANDAs in connection with Ampyra® (dalfampridine), Onglyza® (saxagliptin), and Kombiglyze® (saxagliptin/metformin). [read post]
5 Jun 2013, 12:01 pm
A 23 year old woman has filed a product liability lawsuit against Amylin Pharmaceuticals and Eli Lilly & Co., claiming that she developed thyroid cancer from side effects of Byetta. [read post]
14 Jun 2013, 6:23 pm
In addition to Byetta, Victoza and Bydureon, other drugs highlighted include Januvia (sitagliptin), Janumet (sitagliptin and metformin), Onglyza (saxagliptin) and Tradjenta (linagliptin). [read post]
30 Apr 2015, 3:03 pm
Our clients were busy as well, with cases, conferences, media mentions, and more. [read post]
28 Jul 2013, 9:29 am
Only in this way can I be sure of meeting about the cases that are currently most interesting and compelling. [read post]
29 Mar 2018, 7:50 am
Overview of January 2018 Hearing Session Following the January 25, 2018 hearing session in Miami, Florida, the JPML issued transfer orders centralizing cases and creating new Multidistrict Litigation (“MDL”) in seven out of the thirteen new petitions: MDL No. 2809 – In Re: Onglyza (Sexagliptin) and Kombiglyze XR (Saxagliptin and Metformin) Products Liability Litigation (Transferred to the Honorable Karen K. [read post]
25 Aug 2023, 6:22 pm
Another problem arises from the IARC’s labeling of “probable human carcinogens” made in some cases without any real evidence of carcinogenesis in humans. [read post]
8 Feb 2017, 5:48 am
There are more than 650 cases alleging that these birth control pills which potentially cause deadly blood clots in women. [read post]
5 Jan 2018, 12:00 pm
(Case review done by attorney Tom Lamb) [read post]
